Bleumink GS - Search Results

1

Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.

Bleumink GS, van Duijn CM, Kingma JH, Witteman JC, Hofman A, Stricker BH. Bleumink GS, et al. Am Heart J. 2004 Apr;147(4):685-9. doi: 10.1016/j.ahj.2003.11.016. Am Heart J. 2004. PMID: 15077085

2

Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).

Bleumink GS, Rietveld I, Janssen JA, van Rossum EF, Deckers JW, Hofman A, Witteman JC, van Duijn CM, Stricker BH. Bleumink GS, et al. Am J Cardiol. 2004 Aug 1;94(3):384-6. doi: 10.1016/j.amjcard.2004.04.044. Am J Cardiol. 2004. PMID: 15276114

3

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.

Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Bleumink GS, et al. Eur Heart J. 2004 Sep;25(18):1614-9. doi: 10.1016/j.ehj.2004.06.038. Eur Heart J. 2004. PMID: 15351160

4

Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study.

Bleumink GS, Deinum J, Mosterd A, Witteman JC, Hofman A, Stricker BH. Bleumink GS, et al. Pharmacoepidemiol Drug Saf. 2004 Oct;13(10):703-9. doi: 10.1002/pds.947. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386731

5

Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects.

Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, Deckers JW, Deinum J, van Duijn CM. Schut AF, et al. Among authors: bleumink gs. Eur Heart J. 2004 Dec;25(23):2143-8. doi: 10.1016/j.ehj.2004.08.026. Eur Heart J. 2004. PMID: 15571830

6

C-reactive protein and risk of heart failure. The Rotterdam Study.

Kardys I, Knetsch AM, Bleumink GS, Deckers JW, Hofman A, Stricker BH, Witteman JC. Kardys I, et al. Among authors: bleumink gs. Am Heart J. 2006 Sep;152(3):514-20. doi: 10.1016/j.ahj.2006.02.023. Am Heart J. 2006. PMID: 16923423

7

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.

van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, Stricker BH, Witteman JC. van Vark LC, et al. Among authors: bleumink gs. Eur Heart J. 2006 Oct;27(19):2346-52. doi: 10.1093/eurheartj/ehl230. Epub 2006 Sep 4. Eur Heart J. 2006. PMID: 16952920

8

Antipsychotics and the risk of sudden cardiac death.

Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Stricker BH. Straus SM, et al. Among authors: bleumink gs. Arch Intern Med. 2004 Jun 28;164(12):1293-7. doi: 10.1001/archinte.164.12.1293. Arch Intern Med. 2004. PMID: 15226162

9

The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.

Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Stricker BH. Visser LE, et al. Among authors: bleumink gs. Br J Haematol. 2004 Oct;127(1):85-9. doi: 10.1111/j.1365-2141.2004.05162.x. Br J Haematol. 2004. PMID: 15384981 Free article.

10

Genetic polymorphisms and heart failure.

Bleumink GS, Schut AF, Sturkenboom MC, Deckers JW, van Duijn CM, Stricker BH. Bleumink GS, et al. Genet Med. 2004 Nov-Dec;6(6):465-74. doi: 10.1097/01.gim.0000144061.70494.95. Genet Med. 2004. PMID: 15545741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page